Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis

American Journal of Nephrology

Volumn 25, Issue 3, 2005, Pages 189-195

  Kim, Byung Soo ^a   Doo, Soo Jeon ^a   Mi, Jung Shin ^a   Young, Ok Kim ^a   Ho, Cheol Song ^a   Seung, Hun Lee ^a   Suk, Young Kim ^a   Euy, Jin Choi ^a   Chang, Yoon Sik ^a,b   Byung, Kee Bang ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

C reactive protein; Cardiac dysfunction; Cardiac hypertrophy; Hemodialysis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; TROPONIN T;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT ATRIUM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEMODIALYSIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; VASCULAR ACCESS;

ADULT; C-REACTIVE PROTEIN; CARDIOMEGALY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN; HEART DISEASES; HEART SEPTUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; STROKE VOLUME; TROPONIN T;

EID: 23944510218     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085585     Document Type: Article

References (17)

1. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Pafrey DS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47:884-890.
2. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
3. Yeun JY, Levine RA, Mantadiok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
4. Park CW, Shin YS, Kim CM, Lee SY, Yu SE, Kim SY, Choi EJ, Chang YS, Bang BK: Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002;40:1230-1239.
5. Uehara K, Nomura M, Ozaki Y, Fujinaga H, Ikefuji H, Kimura M, Chikamori K, Nakaya Y, Ito S: High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart Vessels 2003;18:67-74.
6. Boenisch O, Ehmke KD, Heddergott A, Naoum C, Frei U, Schindler R: C-reactive protein and cytokine plasma levels in hemodialysis patients. J Nephrol 2002;15:547-551.
7. Fine A: Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 2002;61:615-620.
8. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin LW: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO study group. Kidney Int 2000;58:346-352.
9. De Simone G, Daniels SR, Devereux RB: Left ventricular mass and body size in normotensive children and adults. J Am Coll Cardiol 1992;20:1251-1260.
10. Linder A, Charra B, Sherrard DJ, Schribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
11. Bailey GL, Hampers CL, Merrill JP: Reversible cardiomyopathy in uremia. Trans Am Soc Artif Intern Organs 1969;13:263-270.
12. Foley RN, Parfrey PS, Samak MJ: Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998;32(suppl 3):S112-S119.
13. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal hemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002;17:1518-1521.
14. Wanner C, Zimmermann J, Schwedler S, Metzger T: Inflammation and cardiovascular risk in dialysis patients. Kidney Int 2002;61(suppl 80):S99-S102.
15. Lowbeer C, Gutierrez A, Gustafsson SA, Norrman R, Hulling J, Seeberger A: Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death. Nephrol Dial Transplant 2002;17:2178-2183.
16. de Filippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W: Cardiac troponinT and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359.
17. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T: Troponin as a risk facor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-2009.